Balance Sheet
Cash Flow Statement
Beginning Cash BalanceCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesFree Cash FlowNet Cash FlowNet IncomeOther Working Capital Changes
Growth Metrics
Income Statement
Others
Ratios

BioScience Health Innovations (BHIC) Cash from Operations (2019 - 2025)

BioScience Health Innovations (BHIC) has disclosed Cash from Operations for 7 consecutive years, with 100696.0 as the latest value for Q4 2025.

  • Quarterly Cash from Operations fell 100.17% to 100696.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 172178.0 through Dec 2025, up 642.53% year-over-year, with the annual reading at 172178.0 for FY2025, 642.53% up from the prior year.
  • Cash from Operations for Q4 2025 was 100696.0 at BioScience Health Innovations, up from 340445.0 in the prior quarter.
  • The five-year high for Cash from Operations was 328309.0 in Q1 2025, with the low at 340445.0 in Q3 2025.
  • Average Cash from Operations over 5 years is 11120.83, with a median of 26468.5 recorded in 2022.
  • The sharpest move saw Cash from Operations tumbled 920.93% in 2021, then soared 783.41% in 2025.
  • Over 5 years, Cash from Operations stood at 5901.0 in 2021, then plummeted by 372.97% to 27910.0 in 2022, then crashed by 102.28% to 56457.0 in 2023, then grew by 10.9% to 50305.0 in 2024, then plummeted by 100.17% to 100696.0 in 2025.
  • According to Business Quant data, Cash from Operations over the past three periods came in at 100696.0, 340445.0, and 285010.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.